Molecular structure of 2-Phenyl-2-(1-piperidinyl)propane, CAS Number: 92321-29-4
2-Phenyl-2-(1-piperidinyl)propane (CAS 92321-29-4)
See product citations (4)
Alternate Names:
1-(1-Methyl-1-phenylethyl)piperidine
Application:
2-Phenyl-2-(1-piperidinyl)propane is an enzyme inhibitor and a selective inactivator of CYP2B6
CAS Number:
92321-29-4
Molecular Weight:
203.32
Molecular Formula:
C14H21N
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
2-Phenyl-2-(1-piperidinyl)propane serves as a compound used in synthetic organic chemistry research, where it is a building block for the synthesis of various complex organic molecules. Its structure, which features both a phenyl ring and a piperidine moiety, makes it a candidate for constructing ligands that can bind to an array of biological targets in mechanistic studies. The compound is particularly interesting to researchers investigating the properties of organic compounds that contain both aromatic and aliphatic nitrogen components, considering their potential to engage in pi-stacking and hydrogen bonding interactions. It is also utilized in the exploration of chemical space in the design of new compounds with potential interactions with enzymes and other proteins. Additionally, 2-Phenyl-2-(1-piperidinyl)propane is involved in catalysis research, where researchers examine its role as a potential intermediate in catalytic cycles or as a ligand that could influence the outcome of chemical reactions.
2-Phenyl-2-(1-piperidinyl)propane (CAS 92321-29-4) References
- Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane. | Chun, J., et al. 2000. Drug Metab Dispos. 28: 905-11. PMID: 10901699
- The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. | Bjornsson, TD., et al. 2003. Drug Metab Dispos. 31: 815-32. PMID: 12814957
- Metabolism of N,N',N'-triethylenethiophosphoramide by CYP2B1 and CYP2B6 results in the inactivation of both isoforms by two distinct mechanisms. | Harleton, E., et al. 2004. J Pharmacol Exp Ther. 310: 1011-9. PMID: 15121764
- Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation. | Turpeinen, M., et al. 2005. Clin Pharmacol Ther. 77: 553-9. PMID: 15961986
- Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6. | Walsky, RL., et al. 2006. J Clin Pharmacol. 46: 1426-38. PMID: 17101742
- New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis. | Korhonen, LE., et al. 2007. Br J Pharmacol. 150: 932-42. PMID: 17325652
- A comparison of 2-phenyl-2-(1-piperidinyl)propane (ppp), 1,1',1''-phosphinothioylidynetrisaziridine (thioTEPA), clopidogrel, and ticlopidine as selective inactivators of human cytochrome P450 2B6. | Walsky, RL. and Obach, RS. 2007. Drug Metab Dispos. 35: 2053-9. PMID: 17682072
- Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. | Khojasteh, SC., et al. 2011. Eur J Drug Metab Pharmacokinet. 36: 1-16. PMID: 21336516
- Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc. | Lu, Y., et al. 2012. Drug Metab Dispos. 40: 2221-30. PMID: 22923690
- In vitro metabolism and pharmacokinetic studies on methylone. | Pedersen, AJ., et al. 2013. Drug Metab Dispos. 41: 1247-55. PMID: 23545806
- Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes. | Bae, SH., et al. 2013. Chem Biol Interact. 205: 11-9. PMID: 23777987
- Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays. | Nirogi, R., et al. 2015. Xenobiotica. 45: 95-106. PMID: 25070627
- Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in Humans. | Shen, J., et al. 2016. Drug Metab Dispos. 44: 1139-47. PMID: 27179126
- Development of a Specific Substrate-Inhibitor Panel (Liver-on-a-Chip) for Evaluation of Cytochrome P450 Activity. | Zakhariants, AA., et al. 2016. Bull Exp Biol Med. 162: 170-174. PMID: 27882460
- Use of hepatocytes isolated from a liver-humanized mouse for studies on the metabolism of drugs: application to the metabolism of fentanyl and acetylfentanyl. | Kanamori, T., et al. 2018. Forensic Toxicol. 36: 467-475. PMID: 29963210
- Preclinical assessment of the ADME, efficacy and drug-drug interaction potential of a novel NAMPT inhibitor. | Liederer, BM., et al. 2019. Xenobiotica. 49: 1063-1077. PMID: 30257601
- Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom). | Kamble, SH., et al. 2019. Xenobiotica. 49: 1279-1288. PMID: 30547698
- Pharmacological significance of the species differences in bupropion metabolism. | Welch, RM., et al. 1987. Xenobiotica. 17: 287-98. PMID: 3107223
- In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine. | Joshi, A., et al. 2020. Cancer Chemother Pharmacol. 86: 633-640. PMID: 32989483
Inhibitor of:
CYP2B6.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
2-Phenyl-2-(1-piperidinyl)propane, 5 mg | sc-206481 | 5 mg | $153.00 | |||
2-Phenyl-2-(1-piperidinyl)propane, 25 mg | sc-206481A | 25 mg | $551.00 | |||
2-Phenyl-2-(1-piperidinyl)propane, 100 mg | sc-206481B | 100 mg | $959.00 | |||
2-Phenyl-2-(1-piperidinyl)propane, 250 mg | sc-206481C | 250 mg | $1533.00 |